Search Results

Royal Philips, a global leader in health technology, radiation therapy leader Elekta, and oncology service provider Mercurius Health announced the signing of a 3-year agreement under which Philips and Elekta will install state-of-the-art diagnostic and therapeutic oncology equipment and associated informatics solutions at Mercurius Health’s newly-acquired Robert Janker Klinik cancer center in Bonn, Germany.

The demand for Elekta’s solutions continued to be strong in the third quarter, the fifth consecutive quarter with underlying order growth, resulting in Elekta’s strongest order backlog ever.

Elekta invites analysts and investors to a presentation of the third quarter 2021/22 at 10:00 a.m. CET on February 24.

Elekta announced that it will appoint Tobias Hägglöv as Chief Financial Officer effective February 1, 2022, taking over from Johan Adebäck.

Elekta announced the presentation of new award-winning abstracts supporting the many benefits of Elekta Unity in treating cancer patients using precision radiation therapy.

Elekta announced that it has established a Sustainability-Linked Bond Framework for issues of sustainability-linked bonds under its Medium Term Note Program.

Elekta invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25.

Elekta announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac.

Elekta announced that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with the addition of 800 to 1,000 additional Elekta linacs in underserved markets.

Elekta invites investors, analysts and financial media representatives to join Elekta’s digital Capital Markets Day on June 7, 2021.